(63) found that metavert, a molecule that inhibits both GSK3B and HDACs activity, could significantly reduce tumour size, prevent metastasis, increase the killing of paclitaxel- and gemcitabine-resistant pancreatic cancer cells. Here, GSK3B is linked to familial pancreatic carcinoma.